BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1618053)

  • 1. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
    Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
    Dig Dis Sci; 1992 Jul; 37(7):1057-64. PubMed ID: 1618053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Georges Brohee Prize 1988-1989. Assimilation of nutritional carbohydrates: influence of hydrolysis.
    Hiele M
    Acta Gastroenterol Belg; 1991; 54(1):3-11. PubMed ID: 2058348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-amylase inhibitors.
    Taylor RH; Barker HM
    Lancet; 1983 May; 1(8335):1228-9. PubMed ID: 6190054
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of starch malabsorption on colonic function and metabolism in humans.
    Scheppach W; Fabian C; Ahrens F; Spengler M; Kasper H
    Gastroenterology; 1988 Dec; 95(6):1549-55. PubMed ID: 3053313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo.
    Madariaga H; Lee PC; Heitlinger LA; Lebenthal E
    Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F; Compagnucci P
    Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of starch malabsorption on fecal bile acids and neutral sterols in humans: possible implications for colonic carcinogenesis.
    Bartram HP; Scheppach W; Heid C; Fabian C; Kasper H
    Cancer Res; 1991 Aug; 51(16):4238-42. PubMed ID: 1868444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the glucosidase inhibitor acarbose in patients with liver cirrhosis.
    Zillikens MC; Swart GR; van den Berg JW; Wilson JH
    Aliment Pharmacol Ther; 1989 Oct; 3(5):453-9. PubMed ID: 2518858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption.
    Taylor RH; Jenkins DJ; Barker HM; Fielden H; Goff DV; Misiewicz JJ; Lee DA; Allen HB; MacDonald G; Wallrabe H
    Diabetes Care; 1982; 5(2):92-6. PubMed ID: 6927727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate malabsorption following acarbose administration.
    Sobajima H; Mori M; Niwa T; Muramatsu M; Sugimoto Y; Kato K; Naruse S; Kondo T; Hayakawa T
    Diabet Med; 1998 May; 15(5):393-7. PubMed ID: 9609361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats.
    Mörmann JE; Schmid R; Mühlemann HR
    Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of alpha-glucosidase inhibition.
    Bischoff H
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies.
    Hollenbeck CB; Coulston AM; Quan R; Becker TR; Vreman HJ; Stevenson DK; Reaven GM
    Am J Clin Nutr; 1983 Oct; 38(4):498-503. PubMed ID: 6414283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the rate of carbohydrate and lipid absorption by the intestine.
    Puls W; Krause HP; Müller L; Schutt H; Sitt R; Thomas G
    Int J Obes; 1984; 8 Suppl 1():181-90. PubMed ID: 6398805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persimmon-Tannin, an α-Amylase Inhibitor, Retards Carbohydrate Absorption in Rats.
    Tsujita T
    J Nutr Sci Vitaminol (Tokyo); 2016; 62(3):192-7. PubMed ID: 27465726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon.
    Wolin MJ; Miller TL; Yerry S; Zhang Y; Bank S; Weaver GA
    Appl Environ Microbiol; 1999 Jul; 65(7):2807-12. PubMed ID: 10388668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.